Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study

A Mansour, E Flecher, M Schmidt, B Rozec… - Intensive Care …, 2022 - Springer
Purpose To describe bleeding and thrombotic events and their risk factors in patients
receiving extracorporeal membrane oxygenation (ECMO) for severe coronavirus disease …

Intracranial hemorrhages on extracorporeal membrane oxygenation: differences between COVID-19 and other viral acute respiratory distress syndrome

B Seeliger, M Doebler, DA Hofmaenner… - Critical care …, 2022 - journals.lww.com
OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) is a potentially lifesaving
procedure in acute respiratory distress syndrome (ARDS) due to COVID-19. Previous …

Anticoagulation management in severe coronavirus disease 2019 patients on extracorporeal membrane oxygenation

Z Guo, L Sun, B Li, R Tian, X Zhang, Z Zhang… - … of Cardiothoracic and …, 2021 - Elsevier
Objective To explore special coagulation characteristics and anticoagulation management
in extracorporeal membrane oxygenation (ECMO)–assisted patients with coronavirus …

Impact of major bleeding and thrombosis on 180‐day survival in patients with severe COVID‐19 supported with veno‐venous extracorporeal membrane oxygenation …

DJ Arachchillage, I Rajakaruna, I Scott… - British Journal of …, 2022 - Wiley Online Library
Bleeding and thrombosis are major complications in patients supported with extracorporeal
membrane oxygenation (ECMO). In this multicentre observational study of 152 consecutive …

Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis

RR Ling, K Ramanathan, JJL Sim, SN Wong, Y Chen… - Critical care, 2022 - Springer
Background Extracorporeal membrane oxygenation (ECMO) has been used extensively for
coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) …

Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study

V Fanelli, M Giani, G Grasselli, F Mojoli, G Martucci… - Critical Care, 2022 - Springer
Background Extracorporeal membrane oxygenation (ECMO) has become an established
rescue therapy for severe acute respiratory distress syndrome (ARDS) in several etiologies …

Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry

RP Barbaro, G MacLaren, PS Boonstra, TJ Iwashyna… - The Lancet, 2020 - thelancet.com
Background Multiple major health organisations recommend the use of extracorporeal
membrane oxygenation (ECMO) support for COVID-19-related acute hypoxaemic …

Thombosis, major bleeding, and survival in COVID-19 supported by veno-venous extracorporeal membrane oxygenation in the first vs second wave: a multicenter …

DJ Arachchillage, A Weatherill, I Rajakaruna… - Journal of Thrombosis …, 2023 - Elsevier
Background Bleeding and thrombosis are major complications of veno-venous (VV)
extracorporeal membrane oxygenation (ECMO). Objectives To assess thrombosis, major …

A case series of devastating intracranial hemorrhage during venovenous extracorporeal membrane oxygenation for COVID-19

AA Usman, J Han, A Acker, SE Olia… - … of Cardiothoracic and …, 2020 - Elsevier
Objective Anticoagulation may be a challenge in coronavirus disease 2019 (COVID-19)
extracorporeal membrane oxygenation due to endothelial injury and dysregulation of …

Extracorporeal membrane oxygenation in patients with COVID-19: an international multicenter cohort study

SJ Raasveld, TSR Delnoij, LM Broman… - Journal of intensive …, 2021 - journals.sagepub.com
Background: To report and compare the characteristics and outcomes of COVID-19 patients
on extracorporeal membrane oxygenation (ECMO) to non-COVID-19 acute respiratory …